← Back to Clinical Trials
Recruiting NCT06167135

NCT06167135 Polycystic Ovary Syndrome, Mitochondrial Dysfunction, Obesity, Insulin Resistance Infertility (POMODORI) Cohort

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06167135
Status Recruiting
Phase —
Sponsor Semmelweis University
Condition Infertility, Female
Study Type OBSERVATIONAL
Enrollment 150 participants
Start Date 2021-09-10
Primary Completion 2033-09-30

Eligibility & Interventions

Sex Female only
Min Age 20 Years
Max Age 45 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 150 participants in total. It began in 2021-09-10 with a primary completion date of 2033-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Enrolling of 150 female patients of fertile age diagnosed with PCOS, insulin resistance, infertility, or mitochondrial disease, and the same number of age- and sex-matched controls are planned. During the research biomarkers already with mitochondrial dysfunction in the scientific literature and common mtDNA abnormalities (deletions, point mutations, copy number changes, etc.) are examined.

Eligibility Criteria

Inclusion Criteria: * Presence of polycystic ovary syndrome (PCOS) or insulin resistance (IR) associated with other multisystemic phenotypes, mitochondrial dysfunction * history of infertility associated with other multisystemic phenotypes, mitochondrial dysfunction * a known history of mitochondrial dysfunction and PCOS and/or IR * general health is good and there is no serious general medical condition that would prevent participation would make participation highly risky Exclusion Criteria: * poor cooperation * refusal to participate in the study

Contact & Investigator

Central Contact

Vera Várhegyi, MD

✉ varhegyi.vera@semmelweis.hu

📞 +36206663493

Frequently Asked Questions

Who can join the NCT06167135 clinical trial?

This trial is open to female participants only, aged 20 Years or older, up to 45 Years, studying Infertility, Female. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06167135 currently recruiting?

Yes, NCT06167135 is actively recruiting participants. Contact the research team at varhegyi.vera@semmelweis.hu for enrollment information.

Where is the NCT06167135 trial being conducted?

This trial is being conducted at Budapest, Hungary.

Who is sponsoring the NCT06167135 clinical trial?

NCT06167135 is sponsored by Semmelweis University. The trial plans to enroll 150 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology